Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · Real-Time Price · USD
0.713
+0.023 (3.32%)
At close: Nov 21, 2024, 4:00 PM
0.725
+0.012 (1.64%)
After-hours: Nov 21, 2024, 6:43 PM EST

Ocean Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-98.59-17.36-62.34-1.65-0.23
Stock-Based Compensation
1.612.3856.55--
Other Operating Activities
84.781.18---
Change in Other Net Operating Assets
3.172.814.741.590.23
Operating Cash Flow
-8.6-0.99-1.05-0.06-
Short-Term Debt Issued
-0.74---
Total Debt Issued
8.110.74---
Net Debt Issued (Repaid)
6.010.74---
Issuance of Common Stock
14.26-1.02--
Other Financing Activities
-10.760.230.10.06-
Financing Cash Flow
9.510.971.110.06-
Net Cash Flow
0.92-0.030.06--
Free Cash Flow
-8.6-0.99-1.05-0.06-
Free Cash Flow Per Share
-0.44-0.06-0.06-0.00-
Levered Free Cash Flow
1.565.2822.33--
Unlevered Free Cash Flow
1.755.3922.33--
Change in Net Working Capital
-7.53-3.09-4.74--
Source: S&P Capital IQ. Standard template. Financial Sources.